Saturday Jun 15
New Market Research Report: Alexza Pharmaceuticals, Inc. - Product Pipeline Review - 2013
The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Valuing Alexza After The Teva Adasuve Deal
On May 8, 2013, Alexza Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. announced that the two companies have entered into an exclusive U.S. license and supply agreement for ADASUVE inhalation powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.
SteadyMed Therapeutics, Inc. Further Strengthens Management Team With ...
SteadyMed Therapeutics, Inc. , a private drug delivery therapeutics company, today announced that Peter Noymer, Ph.D. has joined the company as EVP of R&D and CTO, and Rick White has joined as VP BD and Commercial Operations.
Agendia Appoints Peter W. Schineller as Chief Commercial Officer
Agendia, a leader in molecular cancer diagnostics, today announced the addition of Peter W. Schineller as its Chief Commercial Officer.